CANADA LIFE ASSURANCE Co
InsurancePosition in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1046192
WINNIPEG, A2
Position in CRNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$396,502
+$11,656 QoQ
Shares Held
10,596
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 264 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. CRNX ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $396,502 | 10,596 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $384,846 | 10,596 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $382,361 | 8,214 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $939,665 | 22,561 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $552,738 | 19,219 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $644,605 | 19,219 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $982,667 | 19,219 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $886,022 | 17,339 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $776,613 | 17,339 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $221,973 | 4,742 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $168,720 | 4,742 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $141,027 | 4,742 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,255 | 1,457 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $23,399 | 1,457 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,663 | 1,457 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $28,615 | 1,457 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $27,173 | 1,457 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $31,981 | 1,457 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $41,393 | 1,457 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,669 | 1,457 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,464 | 1,457 | Shares | Defined | 2021-08-11 | |
| 2020-12-31 | $32,340 | 2,292 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $35,915 | 2,292 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $40,155 | 2,292 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $6,688 | 455 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||